2021
DOI: 10.1007/s00268-021-06320-z
|View full text |Cite
|
Sign up to set email alerts
|

Identification of Risk Factors for Acute Kidney Injury from Intravenous Ketorolac in Geriatric Trauma Patients

Abstract: Background Ketorolac is an effective analgesic but the potential for acute kidney injury (AKI) is concerning, particularly in geriatric ''G-60 trauma'' patients. The objectives of this study are to report the incidence of AKI in patients who receive ketorolac, identify risk factors for AKI, and develop a risk factor-guided algorithm for safe utilization. Methods This retrospective cohort study included trauma patients age 60 years and older who received intravenous ketorolac. The primary endpoint was the incid… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 27 publications
(23 reference statements)
0
3
0
Order By: Relevance
“…Ketorolac (mean dose 42.3 mg) was the most commonly used preparation, and no effect size in the form of adjusted OR or relative risk was given as the incidence of kidney injury was only 0.12% [ 15 ]. However, the incidence of acute kidney injury as defined by Kidney Disease Improving Global Outcomes (KDIGO) criteria in the similar population who received ketorolac has been reported to be 2.5% [ 16 ], and thus many kidney injury events might have been left undetected in that study. In a study of younger patients undergoing resection of the gastrointestinal tract and hepatobiliary surgery, NSAIDs given during postoperative days 0 to 3 were not associated with acute kidney injury by postoperative day 7 as defined by KDIGO criteria with adjusted OR of 0.8 [ 17 ].…”
Section: Discussionmentioning
confidence: 99%
“…Ketorolac (mean dose 42.3 mg) was the most commonly used preparation, and no effect size in the form of adjusted OR or relative risk was given as the incidence of kidney injury was only 0.12% [ 15 ]. However, the incidence of acute kidney injury as defined by Kidney Disease Improving Global Outcomes (KDIGO) criteria in the similar population who received ketorolac has been reported to be 2.5% [ 16 ], and thus many kidney injury events might have been left undetected in that study. In a study of younger patients undergoing resection of the gastrointestinal tract and hepatobiliary surgery, NSAIDs given during postoperative days 0 to 3 were not associated with acute kidney injury by postoperative day 7 as defined by KDIGO criteria with adjusted OR of 0.8 [ 17 ].…”
Section: Discussionmentioning
confidence: 99%
“…52,60 Notably, a retrospective cohort of 316 trauma patients over 60 years old and receiving ketorolac reported a 2.5% incidence of acute kidney injury. 61 Multivariate analysis revealed loop diuretics and the total number of comorbidities as predictors of AKI, but not age. Since adverse side effects are more likely at higher dosages and longer durations of use, 52,62 guidelines recommend avoiding chronic use of NSAIDs in geriatric patients except for those meeting certain criteria: failure of other therapies, favorable risk/benefit profile, ongoing monitoring of therapy, and concurrent proton pump inhibitor administration.…”
Section: Concerns Beyond Analgesiamentioning
confidence: 97%
“…AKI in trauma patient is complicated and its cause is diverse, renal ischemia being the commonest etiology. Even though different researches have established that hypotension, rhabdomyolysis, venous thromboembolism, acidosis, shock and infections have been participating factors (4) . AKI has been demonstrated to be accompanied by adverse outcomes among trauma cases and development of AKI is closely accompanied by increased mortality and length of stay (LOS) (5) .…”
Section: Introductionmentioning
confidence: 99%